European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
Endovascular Arch Repair: Endograft Design Options and Worldwide Results.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lescan Mario, Kondov Stoyan, Dimov Aleksandar, Berger Tim, Discher Philipp, Gottardi Roman, Kletzer Joseph, Kreibich Maximilian, Schusterova Ingrid, Czerny Martin
Аннотация
OBJECTIVES: This review evaluates procedural and technical advancements in branched and fenestrated thoracic endovascular aortic repair (B-/F-TEVAR) for aortic arch pathologies, with the main focus on the clinical outcomes, including stroke and mortality.
METHODS: A narrative review of the literature was conducted to assess the evolution of B-/F-TEVAR devices, including branched and fenestrated designs. Key factors such as technical success, perioperative outcomes, and long-term performance were examined across various patient cohorts, with the focus on mortality and stroke.
RESULTS: B-/F-TEVAR achieves high technical success rates (84%-100%), with 30-day mortality and stroke rates typically ranging from 0% to 25% and 3% to 36%, respectively. Fenestrated repairs are particularly suited for pathologies involving the lesser aortic curvature, offering reduced mortality (as low as 2% in some studies), while branched repairs provide greater adaptability for complex anatomies, albeit with higher stroke rates in certain cohorts.
CONCLUSIONS: B-/F-TEVAR has emerged as a feasible treatment option for selected high-risk patients with aortic arch pathology, achieving high technical success. Although outcomes may improve with growing experience, stroke remains a significant complication, and reintervention rates highlight the need for long-term durability.
METHODS: A narrative review of the literature was conducted to assess the evolution of B-/F-TEVAR devices, including branched and fenestrated designs. Key factors such as technical success, perioperative outcomes, and long-term performance were examined across various patient cohorts, with the focus on mortality and stroke.
RESULTS: B-/F-TEVAR achieves high technical success rates (84%-100%), with 30-day mortality and stroke rates typically ranging from 0% to 25% and 3% to 36%, respectively. Fenestrated repairs are particularly suited for pathologies involving the lesser aortic curvature, offering reduced mortality (as low as 2% in some studies), while branched repairs provide greater adaptability for complex anatomies, albeit with higher stroke rates in certain cohorts.
CONCLUSIONS: B-/F-TEVAR has emerged as a feasible treatment option for selected high-risk patients with aortic arch pathology, achieving high technical success. Although outcomes may improve with growing experience, stroke remains a significant complication, and reintervention rates highlight the need for long-term durability.